ImmPORT Therapeutics Inc dba ANTIGEN DISCOVERY INC /
Introducing the World's Fastest System for Fabricating & Screening Proteome Microarrays
Antigen Discovery Inc (ADi, formerly known as ImmPORT Therapeutics Inc)'s revolutionary technology enables fast, comprehensive and high-throughput analysis of immune responses to antigens. It is ideal for vaccine and diagnostics development or clinical monitoring and analysis. ADi's proven platform technology allows for the rapid identification of biomarkers and serodiagnostic antigens across infectious organisms, auto-immune diseases, and cancer. A pre-printed array for simultaneous serological detection of multiple infectious agents is available (learn more about "PathogenChip"). The technology is also available as a custom whole proteome synthesis, micro-array fabrication and analysis service .
The primary competitive benefits are:
- Much faster results: starting from gene sequences and genomic DNA, we express, array and screen all antigens in the proteome within weeks. .
- Much higher success rate : high efficiency cell free expression system with tolerance for toxic genes (> 95% of viral and bacterial genes have been successfully expressed).
- Much better sensitivity and dynamic range: suitable for serum screening assays with minute sample volumes and over a wide range of sample dilution.
- Reliable to use: built in controls (e.g. built in QC elements) to help eliminate false negatives and false positives.
- Much more economic: proprietary technology dramatically reduces the cost and time over conventional approaches. Analysis can be done using standard fluorescence or colorimetric assays.
- Highly Flexible: please contact us to inquire about pre-printed and custom arrays, e.g. entire proteomes or selected antigens/domains. Services include analyses of customer samples and array design.
